Salisbury Foundation Trust

FOI_5461

Internal Reference Number: FOI_5461

Date Request Received: 06/01/2020 09:12:01

Date Request Replied To: 03/02/2020 11:42:52

This response was sent via: By Email

Request Summary: venous thromboembolism treatment protocol and volumes

Request Category: Companies

 
Question Number 1:
Does a specific venous thromboembolism protocol exist for your Trust
If so:
- What date was this protocol put into place
- When is it due for review
 
Answer To Question 1:
Not a specific policy, treatment regimens are included within the policies for Warfarin and also DOAC policy.
 
Question Number 2:
Is there a preferred Direct Oral Anticoagulant (DOAC) or are all utilised within the trust for VTE
 
Answer To Question 2:
All utilised within the Trust
 
Question Number 3:
How many patients have been treated for VTE with a DOAC in the last 12 months
 
Answer To Question 3:
693
 
Question Number 4:
What volume of each DOAC was used to Treat in this same time period
 
Answer To Question 4:
Rivaroxaban = 323; Apixaban = 130; Dabigatran = 19;
Edoxaban = 36
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values